Literature DB >> 11167819

Practical application of minimal residual disease assessment in childhood acute lymphoblastic leukaemia annotation.

N Goulden1, A Oakhill, C Steward.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11167819     DOI： 10.1046/j.1365-2141.2001.02560.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  5 in total

Review 1.  The clinical relevance of detection of minimal residual disease in childhood acute lymphoblastic leukaemia.

Authors:  J Moppett; G A A Burke; C G Steward; A Oakhill; N J Goulden
Journal:  J Clin Pathol       Date:  2003-04       Impact factor: 3.411

2.  A new method for high speed, sensitive detection of minimal residual disease.

Authors:  Xiaohe Liu; H Ben Hsieh; Dario Campana; Richard H Bruce
Journal:  Cytometry A       Date:  2011-09-13       Impact factor: 4.355

3.  Prognostic value of early response to treatment combined with conventional risk factors in pediatric acute lymphoblastic leukemia.

Authors:  Akira Morimoto; Kikuko Kuriyama; Shigeyoshi Hibi; Shinjiro Todo; Takao Yoshihara; Hiroshi Kuroda; Shibsaku Imashuku
Journal:  Int J Hematol       Date:  2005-04       Impact factor: 2.490

Review 4.  Minimal residual disease in acute lymphoblastic leukemia.

Authors:  Dario Campana
Journal:  Semin Hematol       Date:  2009-01       Impact factor: 3.851

Review 5.  Role of minimal residual disease monitoring in adult and pediatric acute lymphoblastic leukemia.

Authors:  Dario Campana
Journal:  Hematol Oncol Clin North Am       Date:  2009-10       Impact factor: 3.722
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.